Unravel the complexities of cancer treatment with patient-level data-driven solutions.
By making intelligent connections, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed. IQVIA helps you
Oncology market approvals supported by IQVIA, August 2019-2020
Oncology drug development is moving from drug-centered to patient-centered. From dose escalation through dose optimization, IQVIA’s teams are here to help you navigate the evolving landscape and make informed decisions quickly.
This webinar explores the latest CAR T-Cell therapy market developments impacting life science companies.
Get unique expert insights from IQVIA’s market research studies and CAR T-cell Monitor & Oncology retrospective chart reviews.
Hear the latest market developments as we review the current treatment landscape and learn about manufacturing processes, advances in treatments, and alternatives to CAR T-cell therapy.
Evidence-based research and dissemination of findings remain a key foundation to advance our collective understanding and interpretation of events, and to take actions that will shape the future for all stakeholders. This annual trend report is intended to contribute to that understanding.
Unravel the complexities of cancer treatment with patient-level data-driven solutions.
Flexible solutions. Responsive teams. Data-driven insights.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Access a dedicated network of European cancer hospitals to capture real world data that reflects the latest clinical practice and perform oncology studies faster.